Northern Trust
ACIU icon

Northern Trust’s AC Immune ACIU Stock Holding History

Northern Trust’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-278,513
Closed -$766K – 4441
2026
Q1 		$766K Sell
278,513
-3,440
-1% -$10.7K ﹤0.01% 3451
2025
Q4 		$885K Hold
281,953
– – ﹤0.01% 3439
2025
Q3 		$815K Sell
281,953
-99,401
-26% -$224K ﹤0.01% 3484
2025
Q2 		$774K Buy
381,354
+4,268
+1% +$7.42K ﹤0.01% 3506
2025
Q1 		$705K Sell
377,086
-25,945
-6% -$65.4K ﹤0.01% 3427
2024
Q4 		$1.09M Buy
+403,031
New +$1.26M ﹤0.01% 3355

Other funds holding ACIU

Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust's ACIU Position: Q2 2026 in Review

Northern Trust sold out of AC Immune (ACIU) in Q2 2026, closing a stake of 278,513 shares — an estimated $766K sold.

Northern Trust first reported a position in ACIU in Q4 2024 and held it in 6 quarters. The position peaked at $1.09M in Q4 2024. 37 funds tracked by Wall St. Rank hold ACIU as of Q2 2026.

  • Northern Trust reported no remaining AC Immune position as of Q2 2026 after selling out during the quarter.
  • Northern Trust sold 278,513 AC Immune shares in Q2 2026, an estimated $766K.
  • Northern Trust first reported a position in AC Immune in Q4 2024 and held it in 6 quarters.
  • Northern Trust's AC Immune position peaked at $1.09M in Q4 2024.
  • 37 funds tracked by Wall St. Rank held AC Immune as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.